Skip to main content
. 2013 Dec 18;8(12):e82990. doi: 10.1371/journal.pone.0082990

Table 3. Analysis of patients' compliance for persistent patients (MPR - Medical Possession Ratio).

Type No. Min ASL associated with min Max ASL associated with max Mean Diff. SD CI 95% Low. Lim. CI 95% Upp. Lim. p-value
Metformin Branded 6410 0.47 Milano city 0.55 Lecco 0.03 0.01 0.02 0.04 <0.0001
A10BA02 Generic 7688 0.46 Lecco 0.58 Melegnano
Amlodipine Branded 11435 0.75 Milano city 0.84 Melegnano 0.04 0.01 0.04 0.05 <0.0001
C08CA01 Generic 5101 0.79 Milano city 0.87 Melegnano
Simvastatin Branded 6355 0.42 Milano city 0.48 Melegnano e Lecco 0.03 0.01 0.02 0.04 <0.0001
C10AA01 Generic 10133 0.45 Milano city 0.50 Melegnano
Sertraline Branded 3822 0.63 Milano city 0.68 Bergamo e Melegnano 0.03 0.01 0.01 0.04 0.0003
N06AB06 Generic 3176 0.63 Lecco 0.72 Melegnano
Propafenone Branded 805 0.62 Milano city 0.72 Melegnano 0.04 0.02 −0.01 0.08 N.S.
C01BC03 Generic 328 0.65 Lecco 0.83 Melegnano
Alendronate Branded 1821 0.68 Lecco e Pavia 0.73 Melegnano 0.01 0.01 −0.01 0.03 N.S.
M05BA04 Generic 1605 0.69 Milano city 0.74 Bergamo

ASL: Local Healthcare Units. ASLs enrolled: Milano city; Lecco; Bergamo; Pavia; Milano2.

DDD: Defined Daily Dose.

N.S. not statistically significant.

Inline graphic